Showing results (81-90 of 745) with videos related to
Sort By:
Pageof 75
Current Diabetes Reports|February 5, 2009
Managing diabetic dyslipidemia: beyond statin therapyHemanth Neeli, Ram Gadi, Daniel J RaderCurrent Opinion in Lipidology|August 8, 2014
Sortilin and lipoprotein metabolism: making sense out of complexityAlanna Strong, Kevin Patel, Daniel J RaderCurrent Controlled Trials in Cardiovascular Medicine|November 21, 2001
Gene therapy for lipid disordersMasa-aki Kawashiri Ma, Daniel J RaderCurrent Cardiology Reports|November 6, 2017
HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human GeneticsCecilia Vitali, Sumeet A Khetarpal, Daniel J RaderAtherosclerosis|December 17, 2009
The effect of PPAR-alpha agonism on apolipoprotein metabolism in humansAshish Shah, Daniel J Rader, John S MillarTrends in Cardiovascular Medicine|July 21, 2004
Endothelial lipase: a modulator of lipoprotein metabolism upregulated by inflammationUli C Broedl, Weijun Jin, Daniel J RaderJournal of Clinical Lipidology|December 10, 2013
JCL Roundtable: diagnosis of severe familial hypercholesterolemiaW Virgil Brown, Daniel J Rader, John KaneClinical Lipidology|November 7, 2014
Monogenic causes of elevated HDL cholesterol and implications for development of new therapeuticsDaniel B Larach, Marina Cuchel, Daniel J RaderCirculation Research|September 24, 2005
Apolipoprotein E suppresses the type I inflammatory response in vivoKamilah Ali, Melissa Middleton, Ellen Puré, et al.Journal of the American College of Cardiology|June 7, 2008
Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approachesEmil M deGoma, Rolando L deGoma, Daniel J RaderPageof 75